Ireland’s Shire Pharmaceuticals on Thursday faced the prospect of a bidding war after rejecting a $60-billion takeover from Japan’s Takeda, as Botox-maker Allergan revealed it was mulling an offer.
Ireland’s Shire Pharmaceuticals on Thursday faced the prospect of a bidding war after rejecting a $60-billion takeover from Japan’s Takeda, as Botox-maker Allergan revealed it was mulling an offer.